Hypnosis app aims to tame hot flashes for breast cancer patients

NCT ID NCT06552091

Recruiting now Symptom relief Sponsor: Institut de Cancérologie de Lorraine Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Aug 05, 2026 · Updated 3 times

Summary

This study tests whether a guided digital self-hypnosis program can reduce hot flashes in women with breast cancer who are on hormone therapy. Hot flashes are a common side effect that often leads patients to stop treatment, raising the risk of cancer returning. Over three weeks, 76 participants will practice daily self-hypnosis sessions, and researchers will track changes in hot flash frequency and severity, as well as quality of life and sleep.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: guided digital self-hypnosis sessions
What this could lead to: If it works, this could offer a drug-free way to manage hot flashes, helping patients stick with their hormone therapy and improve their quality of life.
What could go wrong: This is a small, early-phase trial with only 76 participants, so results may not apply to everyone. Self-hypnosis may not work for all, and the effect might be modest.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER FEMALE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm female breast carcinoma Hot Flashes

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST CANCER FEMALE

Contacts and locations

Locations

Institut de Cancerologie de Lorraine
RECRUITING

Vandœuvre-lès-Nancy, 54500, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.